₹0.30
(Market cap
₹73 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
47.2
P/B Ratio
2.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
3.2 %
-
ROCE
3 %
-
Industry P/E
46.93
-
EV/EBITDA
73.5
-
Debt to Equity
0
-
Book Value
₹17.6
-
EPS
₹1.6
-
Face value
10
-
Shares outstanding
14,353,000
10 Years Aggregate
CFO
₹-3.34 Cr
EBITDA
₹-6.33 Cr
Net Profit
₹-8.33 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bacil Pharma
| 43.4 | -8.8 | 4.3 | 23.0 | 95.8 | 46.2 | 29.2 |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bacil Pharma
| -33.1 | 736.0 | -31.7 | 31.5 | 51.0 | 148.4 | -13.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bacil Pharma
|
51.1 | 73.3 | 0.0 | 1.3 | -- | 5.2 | 47.2 | 2.9 |
| 3,000.6 | 24,577.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69 | 14.9 | |
| 754.2 | 14,832.7 | 7,344.9 | 670.6 | 10.9 | 13.7 | 22 | 2.6 | |
| 428.8 | 16,406.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.5 | 4.2 | |
| 782.6 | 19,421.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 991.8 | 15,788.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.6 | 2.2 | |
| 1,791.1 | 20,554.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 174.2 | 23,155.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 460.4 | 18,574.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.7 | 3.8 | |
| 1,771.0 | 28,787.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 135.2 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Bacil Pharma
Bacil Pharma Limited manufactures and sells pharmaceuticals, medicinal chemicals, and botanical products. The company was incorporated in 1987 and is based in Mumbai, India.
-
Incorporated
1987
-
Chairman
--
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsAudited Financial Results For 31St March 2026
22-May-2026Clarification On Price Movement
24-Feb-2026Clarification sought from Bacil Pharma Ltd
24-Feb-2026No News & Announcements are available.
FAQs for Bacil Pharma
What is the current share price of Bacil Pharma Ltd Today?
The share price of Bacil Pharma Ltd is ₹51.09 (BSE) as of 27-May-2026 IST. Bacil Pharma Ltd has given a return of 95.76% in the last 3 years.
What is the current PB & PE ratio of Bacil Pharma Ltd?
The P/E ratio of Bacil Pharma Ltd is 47.16 times as on 27-May-2026, a 0 premium to its peers’ median range of 46.93 times.
The P/B ratio of Bacil Pharma Ltd is 2.91 times as on 27-May-2026, a 25 discount to its peers’ median range of 3.88 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
140.14
|
2.28
|
|
2024
|
0.00
|
14.96
|
|
2023
|
0.00
|
6.98
|
|
2022
|
0.00
|
5.75
|
|
2021
|
0.00
|
2.44
|
What is the 52 Week High and Low of Bacil Pharma Ltd?
The 52-week high and low of Bacil Pharma Ltd are Rs 61.80 and Rs 26.69 as of 27-May-2026.
What is the market cap of Bacil Pharma Ltd?
Bacil Pharma Ltd has a market capitalisation of ₹ 73 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bacil Pharma Ltd?
Before investing in Bacil Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.